Integer Holdings Corporation logo
Integer Holdings Corporation ITGR
$ 86.78 0.32%

Annual report 2025
added 02-23-2026

report update icon

Integer Holdings Corporation Financial Statements 2011-2026 | ITGR

Annual Financial Statements Integer Holdings Corporation

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

2.98 B 4.58 B 3.34 B 2.44 B 2.77 B 2.9 B 2.86 B 2.61 B 1.63 B 1.02 B 1.26 B 1.08 B - 639 M 539 M

Shares

34.7 M 33.6 M 33.3 M 33.1 M 33 M 32.8 M 32.6 M 32.6 M 32.1 M 26.4 M 26 M 25.3 M - 23.6 M 23.6 M

Historical Prices

85.7 136 100 73.6 83.9 88.2 90.2 91 51 36.1 37.8 53.1 43.3 27.1 24.8

Net Income

103 M 120 M 90.6 M 66.4 M 96.8 M 77.3 M 96.3 M 168 M 66.7 M -7.59 M 55.5 M 36.3 M - -4.8 M 33.1 M

Revenue

1.85 B 1.72 B 1.56 B 1.33 B 1.22 B 1.07 B 1.26 B 1.22 B 1.14 B 800 M 688 M 664 M - 646 M 569 M

Cost of Revenue

1.35 B 1.26 B 1.15 B 986 M 884 M 788 M 903 M 852 M 782 M 738 M 456 M 445 M - 445 M 388 M

Gross Profit

500 M 459 M 410 M 346 M 337 M 286 M 355 M 363 M 354 M 235 M 231 M 219 M - 202 M 180 M

Operating Income

221 M 208 M 163 M 113 M 136 M 121 M 158 M 156 M 126 M 92.9 M 75.7 M 61.3 M - 25.8 M 61.7 M

Interest Expense

-53.2 M -3.52 M -975 K 899 K 31.6 M 38.2 M 52.5 M 99.3 M 64 M 68.3 M 4.25 M 11.3 M - 18.1 M 16.9 M

EBITDA

352 M 319 M 262 M 205 M 217 M 200 M 244 M 278 M 228 M 57.8 M 113 M 97.3 M - 72.2 M 109 M

Operating Expenses

279 M 251 M 247 M 233 M 201 M 165 M 189 M 173 M 228 M 222 M 156 M 158 M - 176 M 119 M

General and Administrative Expenses

212 M 185 M 173 M 158 M 141 M 109 M 139 M 116 M 120 M 92.8 M 83.6 M 82.3 M - 74.8 M 72.5 M

All numbers in USD currency

Quarterly Income Statement Integer Holdings Corporation

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

35.1 M 35 M 33.9 M 33.5 M 33.7 M 33.6 M 33.5 M 33.3 M 33.3 M 33.3 M 33.3 M 33.2 M 33.1 M 33.1 M 33.1 M 33.1 M 33 M 33 M 33 M 32.9 M 32.9 M 32.8 M 32.8 M 32.7 M 32.7 M 32.6 M 32.5 M 32.5 M 32.2 M 32 M 31.9 M 31.9 M 31.6 M 31.3 M 31 M 30.9 M 30.8 M 30.8 M 30.7 M 25.1 M 25.5 M 25.5 M 25.3 M 24.4 M 24.9 M 24.8 M 24.6 M - 24 M 23.9 M 23.8 M 23.7 M 23.6 M 23.6 M 23.4 M 23.4 M 23.3 M 23.2 M 23.2 M

Net Income

39.7 M 37 M -22.5 M - 35.4 M 31.2 M 20.5 M - 27.3 M 24 M 13.1 M - 16.1 M 20.8 M 11.4 M - 22.1 M 29.4 M 21.5 M - 30.3 M 389 K 31.1 M 11 M 30.6 M 33.1 M 21.7 M 19.2 M -8.3 M 23.1 M 13.1 M 54.7 M 19.9 M 9.56 M 2.95 M 7.93 M 11.5 M -770 K -12.7 M 14.2 M 22 K 9.28 M 8.01 M 9.78 M 14 M 12.3 M 14.9 M - 11.1 M 9.75 M 5.66 M -5.56 M -7.56 M 3.85 M 4.47 M 5.64 M 6.99 M 8.55 M 11.9 M

Revenue

468 M 476 M 437 M - 431 M 428 M 408 M - 397 M 400 M 379 M - 343 M 350 M 311 M - 306 M 312 M 290 M 269 M 236 M 240 M 328 M 326 M 304 M 314 M 315 M 303 M 305 M 314 M 382 M 390 M 363 M 281 M 345 M 360 M 347 M 348 M 332 M 170 M 147 M 175 M 161 M 177 M 172 M 172 M 174 M - 168 M 171 M 148 M 159 M 161 M 167 M 159 M 142 M 132 M 147 M 149 M

Cost of Revenue

342 M 347 M 317 M - 315 M 311 M 300 M - 292 M 294 M 282 M - 256 M 257 M 229 M - 224 M 223 M 206 M - 178 M 182 M 232 M - 210 M 217 M 226 M - 213 M 216 M 209 M - 197 M 192 M 254 M - 249 M 252 M 241 M - 95 M 117 M 109 M - 114 M 114 M 117 M - 112 M 114 M 99.5 M - 110 M 115 M 112 M - 89.8 M 99.9 M 102 M

Gross Profit

126 M 129 M 120 M - 117 M 117 M 108 M - 105 M 106 M 96.7 M - 86.7 M 92.9 M 81.5 M - 81.9 M 88.7 M 84.5 M 73.2 M 57.9 M 57.9 M 96.7 M 76 M 93.4 M 97 M 88.6 M 88.4 M 91.9 M 98.8 M 83.5 M 93.6 M 89.2 M 89.2 M 82 M 92.9 M 97.9 M 96 M 91.5 M 57.2 M 51.6 M 58 M 52.4 M 57.4 M 58.1 M 58.5 M 57.6 M - 55.9 M 57.3 M 48.7 M 51.9 M 51 M 51.9 M 46.9 M 44.7 M 41.9 M 46.6 M 47.2 M

Operating Income

56.4 M 59.3 M 49.6 M - 58 M 54.5 M 38.7 M - 48.8 M 41.6 M 34.2 M - 29.3 M 32.7 M 22.5 M - 33.1 M 39.4 M 34.6 M - 39.8 M 9.18 M 44.1 M - 46.5 M 49.3 M 39.2 M - 41.5 M 44.4 M 30 M - 35.8 M 36.1 M 26.5 M - 36.9 M 29.3 M 11.1 M - 1.2 M 13 M 9.39 M - 16.2 M 19.5 M 22.5 M - 17 M 17.1 M 14.3 M - 2.13 M 11.1 M 11.2 M - 12.9 M 18.3 M 18 M

Interest Expense

-1.13 M -3.98 M -47.9 M - -916 K 127 K -1.01 M - -580 K -359 K 17.3 M - 10.7 M 7.77 M 5.97 M - 10.1 M 7.53 M 8.53 M - 9.37 M 9.27 M 10.4 M - 12.3 M 13.6 M 13.8 M - 54.5 M 15.2 M 15.6 M - 15.8 M 15.1 M 28.9 M - 27.9 M 27.9 M 27.6 M - 5.82 M 1.21 M 1.12 M - 1.05 M 1.07 M 1.08 M - 1.52 M 1.44 M 6.99 M - 4.4 M 4.42 M 4.36 M - 4.12 M 4.4 M 4.27 M

EBITDA

72.7 M 75.5 M 79.4 M - 71.6 M 68.1 M 64.9 M - 61.8 M 54.7 M 58.3 M - 41.4 M 45 M 45 M - 93.6 M 49.7 M 54.9 M - 98.8 M 48.3 M 63.6 M - 104 M 87.9 M 58.8 M - 110 M 92.9 M 56.4 M - 110 M 85.5 M 51.2 M - 104 M 74.3 M 33.5 M - 28.1 M 31.2 M 18.6 M - 44.1 M 38.1 M 31.8 M - 43.7 M 35 M 23.1 M - 36.2 M 33.2 M 22.3 M - 40 M 36.3 M 26.8 M

Operating Expenses

69.7 M 69.8 M 70.8 M - 58.6 M 62.9 M 69.6 M - 56.2 M 64.2 M 62.5 M - 57.5 M 60.2 M 59 M - 48.8 M 49.4 M 49.9 M - 18.2 M 48.7 M 52.6 M - 46.9 M 47.6 M 49.4 M - 50.5 M 54.4 M 53.5 M - 53.4 M 53.1 M 64.7 M - 61 M 66.8 M 80.3 M - 50.5 M 44.9 M 43 M - 41.9 M 38.9 M 35.1 M - 38.9 M 40.2 M 34.4 M - 48.8 M 40.8 M 35.7 M - 29 M 28.3 M 29.2 M

General and Administrative Expenses

50.5 M 52.9 M 51.2 M - 44.8 M 46.5 M 46.4 M - 41.4 M 45.8 M 41.9 M - 38.2 M 41.8 M 39.6 M - 34.3 M 35.4 M 35.5 M - 3.61 M 33.9 M 36.5 M - 32.9 M 33.1 M 35 M - 34.1 M 36.8 M 36.4 M - 35.1 M 35.1 M 39.5 M - 36.3 M 37.6 M 41.9 M - 22.3 M 24.1 M 22.6 M - 22.1 M 21.9 M 21.8 M - 21.6 M 22.2 M 20.1 M - 20.3 M 20.7 M 19 M - 17.8 M 17.6 M 18.6 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Integer Holdings Corporation ITGR
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Integer Holdings Corporation plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
$ 39.08 -1.83 % $ 5.82 K usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 7.79 3.73 % $ 559 M israelIsrael
FONAR Corporation FONAR Corporation
FONR
$ 18.49 -0.38 % $ 121 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 9.41 -2.39 % $ 1.27 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 43.34 -5.35 % $ 1.35 B usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.45 2.84 % $ 23.4 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 104.65 0.88 % $ 1.33 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
AxoGen AxoGen
AXGN
$ 29.78 -2.84 % $ 1.37 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 3.18 -3.05 % $ 110 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.52 -5.19 % $ 53.4 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.53 - $ 59.8 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Medigus Ltd. Medigus Ltd.
MDGS
- 10.28 % $ 55.5 M israelIsrael
Medtronic PLC Medtronic PLC
MDT
$ 96.73 -1.38 % $ 124 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.79 5.78 % $ 43 M usaUSA
Align Technology Align Technology
ALGN
$ 182.92 -3.23 % $ 13.7 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Butterfly Network Butterfly Network
BFLY
$ 3.73 -3.37 % $ 790 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.96 -3.54 % $ 148 M franceFrance
Abbott Laboratories Abbott Laboratories
ABT
$ 113.53 -0.49 % $ 198 B usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 13.02 -2.62 % $ 516 M curacaoCuracao
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 73.88 -3.07 % $ 109 B usaUSA
PAVmed PAVmed
PAVM
$ 9.94 -0.4 % $ 71.9 M usaUSA
Penumbra Penumbra
PEN
$ 340.23 -0.61 % $ 13.2 B usaUSA